company background image
ASC

Ascendis Health JSE:ASC Stock Report

Last Price

R0.61

Market Cap

R380.9m

7D

-4.7%

1Y

-28.2%

Updated

27 Jan, 2023

Data

Company Financials

ASC Stock Overview

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally.

ASC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

Ascendis Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ascendis Health
Historical stock prices
Current Share PriceR0.61
52 Week HighR0.88
52 Week LowR0.48
Beta0.66
1 Month Change10.91%
3 Month Change-10.29%
1 Year Change-28.24%
3 Year Change-38.38%
5 Year Change-93.90%
Change since IPO-94.50%

Recent News & Updates

Recent updates

Shareholder Returns

ASCZA PharmaceuticalsZA Market
7D-4.7%-0.2%0.4%
1Y-28.2%-22.0%1.2%

Return vs Industry: ASC underperformed the ZA Pharmaceuticals industry which returned -22% over the past year.

Return vs Market: ASC underperformed the ZA Market which returned 1.2% over the past year.

Price Volatility

Is ASC's price volatile compared to industry and market?
ASC volatility
ASC Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement5.0%
10% most volatile stocks in ZA Market12.4%
10% least volatile stocks in ZA Market2.9%

Stable Share Price: ASC is more volatile than 75% of ZA stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ASC's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of ZA stocks.

About the Company

FoundedEmployeesCEOWebsite
2008n/aA. Neethlinghttps://www.ascendishealth.com

Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa, Cyprus, Spain, Hungary, Romania, and internationally. The company operates through Consumer Health, Pharma, and Medical Devices segments. It offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names.

Ascendis Health Limited Fundamentals Summary

How do Ascendis Health's earnings and revenue compare to its market cap?
ASC fundamental statistics
Market CapR380.87m
Earnings (TTM)-R759.03m
Revenue (TTM)R1.56b

0.2x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ASC income statement (TTM)
RevenueR1.56b
Cost of RevenueR889.40m
Gross ProfitR670.05m
Other ExpensesR1.43b
Earnings-R759.03m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.22
Gross Margin42.97%
Net Profit Margin-48.67%
Debt/Equity Ratio135.3%

How did ASC perform over the long term?

See historical performance and comparison